National Institute of Dental & Craniofacial Research; Notice of Closed Meeting, 1110 [2024-00249]
Download as PDF
<![CDATA[
1110
Federal Register / Vol. 89, No. 6 / Tuesday, January 9, 2024 / Notices
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research; Special
Grants Review Committee.
Date: February 22–23, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental &
Craniofacial Research, 6701 Democracy
Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas John O’Farrell,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, National Institute of Dental &
Craniofacial Research, 6701 Democracy
Blvd., Bethesda, MD 20892, 301–402–8559,
tom.ofarrell@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 4, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00249 Filed 1–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation for Public Comments on
Questions From the Task Force on
Maternal Mental Health
Office on Women’s Health,
Office of the Assistant Secretary for
Health, Office of the Secretary;
Substance Abuse and Mental Health
Services Administration (SAMHSA),
U.S. Department of Health and Human
Services (HHS)
ACTION: Notice of request for
information
khammond on DSKJM1Z7X2PROD with NOTICES
AGENCY:
VerDate Sep<11>2014
16:38 Jan 08, 2024
Jkt 262001
The Task Force on Maternal
Mental Health (Task Force), which is
being implemented as a subcommittee
of the SAMHSA Advisory Committee
for Women’s Services (ACWS), solicits
public comments on a set of questions
concerning the context, policies,
effectiveness, promising practices, and
limitations and gaps related to
prevention and treatment of maternal
mental health conditions and substance
use disorders (inclusive of alcohol use/
misuse) and its complications. The Task
Force is required to solicit public
comments, as appropriate, from
stakeholders for the purposes of
developing a report that analyzes and
evaluates the state of maternal mental
health programs at the Federal level and
identifies best practices with respect to
maternal mental health and substance
use disorders as well as a national
strategy for improving maternal mental
health. The taskforce will be
highlighting recommendations that fall
within the pregnancy and postpartum
(up to 1 year after birth) periods for
individuals with or at risk for mental
health and substance use conditions.
DATES: Electronic or written/paper
comments will be accepted through
midnight eastern standard time (EST)
January 31, 2024.
ADDRESSES: The set of questions is
available in the SUPPLEMENTARY
INFORMATION section below. Public
comments can be submitted in the
following ways:
• Electronic submissions can be filed
online at https://www.regulations.gov by
following the ‘‘Instructions for Public
Comments’’ section below. Comments
submitted electronically, including
attachments, will be posted to the
docket unchanged. Evidence and
information supporting your comment
can be submitted as attachments. Please
provide your contact information or
organization name on the web-based
form for follow up by the Task Force.
• If you prefer to comment on paper,
mail your comment to the following
address: 5600 Fishers Lane, Suite
18E01, Rockville, MD 20857. For mailed
submissions, OWH/SAMHSA will post
your comment, as well as any
attachments, to https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket ID into the ‘‘Search’’ box and
follow the prompts.
FOR FURTHER INFORMATION CONTACT:
Valerie Kolick, Designated Federal
Officer, Advisory Committee for
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Women’s Services, U.S. Department of
Health and Human Services, Substance
Abuse and Mental Health Services
Administration, 5600 Fishers Lane,
Suite 18E01, Rockville, MD 20857.
Phone: 240–276–1738 or Email:
valerie.kolick@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION: Section
1113 of the Consolidated
Appropriations Act, 2023 (Pub. L. 117–
328) requires the HHS Secretary to
establish a Task Force on Maternal
Mental Health or incorporate the duties,
public meetings, and reports specified
into existing relevant Federal
committees or working groups. The
Task Force consists of representatives of
specific federal agencies and nonfederal individuals and entities who
represent diverse disciplines and views.
The Task Force will evaluate and make
recommendations to the ACWS for
further deliberation regarding
improvements and coordination for
Federal activities that address maternal
mental health and co-occurring
substance use disorders. The ACWS will
make final recommendations to the
Secretary of Health and Human Services
and to Congress.
The Task Force invites members of
the public to comment on any issues or
concerns they believe are relevant or
appropriate to the state of maternal
mental health programs at the Federal
level, and identification of best practices
with respect to maternal mental health
and substance use. Specifically, the
Task Force requests public comment on
the following questions:
1. Data, Research and Quality
Improvement:
• What are the priority outcomes for
pregnant and postpartum individuals
with substance use disorder and/or
mental health conditions?
• How would you define quality care
for pregnant and postpartum
individuals with substance use
disorders and/or mental health
conditions?
• What are the priority research
questions and gaps related to maternal
substance use disorder and/or mental
health conditions that must be
addressed to improve services and
outcomes for individuals while
pregnant and postpartum?
2. Prevention, Screening and
Diagnosis:
• What is lacking and what is
working to support maternal emotional
health, and substance use and wellbeing during pregnancy and after?
• What steps should be taken to
ensure that approaches to detecting
maternal emotional health issues and
substance use challenges are culturally
appropriate?
E:\FR\FM\09JAN1.SGM
09JAN1
]]>Agencies
[Federal Register Volume 89, Number 6 (Tuesday, January 9, 2024)]
[Notices]
[Page 1110]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00249]
[[Page 1110]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial
Research; Special Grants Review Committee.
Date: February 22-23, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental & Craniofacial Research,
6701 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas John O'Farrell, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, National Institute of Dental & Craniofacial Research,
6701 Democracy Blvd., Bethesda, MD 20892, 301-402-8559,
[email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: January 4, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00249 Filed 1-8-24; 8:45 am]
BILLING CODE 4140-01-P
